CDR
Novavax 2024-2025 formula COVID-19 vaccine available at major pharmacies across the U.S.
Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwide
NACDS fighting for PBM reform in California
The National Association of Chain Drug Stores (NACDS) is joining with California State Senator Scott Wiener (D), the California Chronic Care Coalition and the California Pharmacists Association to urge the enactment of needed pharmacy benefit manager (PBM) reforms in the state.
Walgreens to pay $106.8M to settle DoJ claims of overbilling
As part of the resolution, Walgreens received credit under the department’s guidelines for taking disclosure, cooperation and remediation into account in False Claims Act cases.
Retail sales stayed strong in August, despite sluggish job market
CNBC/NRF Retail Monitor finds total sales were up 2.08% year over year for the first eight months of the year.
NACDS, American Diabetes Association team to promote nutrition security
The #NourishMyHealth public education campaign to be featured at the ADA's Tour de Cure and Step Out Walk to Stop Diabetes events.
Hy-Vee named Best Grocery Store in America in USA TODAY’s 10 Best Readers’ Choice Awards
This is the first year Hy-Vee has ranked No. 1 on the list.
Zydus announces exclusive licensing and supply agreement
Company has entered into an exclusive licensing and supply agreement with Viwit Pharmaceuticals (Viwit).
American Lung Association and CVS Health Foundation team on new project
CVS Health Foundation is investing $3.5 million nationwide to combat this health issue and will pilot it first in Phoenix through a new project with American Lung Association.
CVS Pharmacy birth control prescribing rolls out in Massachusetts
CVS pharmacists can now evaluate patients and prescribe hormonal contraceptives.
Deloitte: Holiday retail sales expected to rise 2.3% to 3.3%
E-commerce holiday sales projected to grow between 7% and 9%, compared to 2023 season.
Kroger posts solid Q2 performance, reaffirms full-year guidance
The company's strategic initiative, "Leading with Fresh and Accelerating with Digital," continues to drive long-term sustainable growth.
Study reports GLP1R innovator drugs driving over $6.2 billion in licensing agreement deals in 2024
Biopharmaceutical companies are now focusing on advancing these drugs to enhance efficacy and expand their therapeutic scope beyond type 2 diabetes and obesity.
NACDS continues to press for federal PBM reform
NACDS: “Given the intolerable nature of market-dominant PBMs’ practices and their far-reaching negative effects, the reforms that now enjoy bipartisan and bicameral consensus must be considered ‘must-pass’ legislation in the 118th Congress”